JP Morgan Chase’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

JP Morgan Chase’s Portfolio HWEL Stock Details HWEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$1.04M	–	8027
2023 Q3	$1.04M	Sell	100,000 -1,190,000	-92%	-$12.3M	﹤0.01%	4046
2023 Q2	$13.3M	Buy	+1,290,000	New	+$13.2M	﹤0.01%	2039

JP Morgan Chase's HWEL Position: Q4 2023 in Review

JP Morgan Chase sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q4 2023, closing a stake of 100,000 shares — an estimated $1.04M sold.

JP Morgan Chase first reported a position in HWEL in Q2 2023 and held it in 2 quarters. The position peaked at $13.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold HWEL as of Q4 2023.

JP Morgan Chase reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q4 2023 after selling out during the quarter.
JP Morgan Chase sold 100,000 Healthwell Acquisition Corp. I Class A Common Stock shares in Q4 2023, an estimated $1.04M.
JP Morgan Chase first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q2 2023 and held it in 2 quarters.
JP Morgan Chase's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $13.3M in Q2 2023.
0 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.